✦ LIBER ✦

Cyclophosphamide followed by Intravenous Targeted Busulfan for Allogeneic Hematopoietic Cell Transplantation: Pharmacokinetics and Clinical Outcomes

✍ Scribed by Rezvani, Andrew R.; McCune, Jeannine S.; Storer, Barry E.; Batchelder, Ami; Kida, Aiko; Deeg, H. Joachim; McDonald, George B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous busulfan for allogeneic hema

✍ Dalle, J H; Wall, D; Theoret, Y; Duval, M; Shaw, L; Larocque, D; Taylor, C; Gard 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Pharmacokinetic Disposition and Clinical

✍ Tal Schechter; Yaron Finkelstein; John Doyle; Zulfikarali Verjee; Myla Moretti; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Cyclophosphamide following Targeted Oral

✍ Jeannine S. McCune; Ami Batchelder; H. Joachim Deeg; Ted Gooley; Scott Cole; Bri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 308 KB

Pharmacokinetic targeting of intravenous

✍ Joseph Pidala; Jongphil Kim; Claudio Anasetti; Mohamed A Kharfan-Dabaja; Taiga N 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 484 KB

Once-daily intravenous busulfan given wi

✍ J.A Russell; H.T Tran; D Quinlan; A Chaudhry; P Duggan; C Brown; D Stewart; J.D 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 173 KB

High-Dose Carmustine, Etoposide, and Cyc

✍ Lisa Y. Law; Sandra J. Horning; Ruby M. Wong; Laura J. Johnston; Ginna G. Laport 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 178 KB